Comparing TelosRX and MDWatch is unusual, because these two are not really built for the same person. MDWatch is designed around seniors on Medicare, with monthly video visits, a connected scale and a route to FDA-approved GLP-1s at a $50 copay for those who qualify. TelosRX is a cash-pay, fully asynchronous service for people who want a low published price and a choice of formats. If you are on Medicare and you qualify for MDWatch's programme, it is very likely the better option, and this article says so plainly.
If you are 65 or over and on Medicare, start with MDWatch. A $50 copay for an FDA-approved GLP-1 beats any cash price, including ours. If you are paying cash, want a five-minute intake with no scheduled consult, or want a needle-free or microdosed route, TelosRX is the better fit.
Start your intake →Quick comparison: TelosRX vs MDWatch
Compounded medications are not FDA-approved. Any prescription is subject to medical approval by a licensed provider, and approval is not guaranteed. Individual results vary.
Start here: are you on Medicare?
Most comparison articles bury the answer. This one should not, because for a large group of readers the decision is straightforward.
MDWatch advertises a Medicare GLP-1 Bridge programme offering FDA-approved GLP-1 medication for as little as a $50 copay for people who qualify, with visits and labs covered. FDA-approved medication has been evaluated by the FDA for safety, efficacy and quality. Compounded medication, whether from MDWatch, from TelosRX or from anyone else, has not.
So if you are eligible for that programme, you would be getting a more rigorously evaluated product at a lower cost than any cash-pay compounded plan on the market, ours included. That is not a close call, and we would rather tell you than have you find out later.
Two caveats worth carrying into that conversation. Coverage depends on your specific plan, your diagnosis and current Medicare rules, so confirm your own eligibility directly rather than assuming. And MDWatch's own pricing makes clear that the $50 figure applies to the Medicare route: if you do not qualify, its compounded tirzepatide is a flat $140 cash price.
What is TelosRX?
TelosRX is an online-first, LegitScript-certified telehealth service focused on GLP-1 weight management.
The process is asynchronous. You complete a short intake online, and a US-licensed provider reviews it, typically within hours. There is no appointment to schedule and no video call to attend.
Medications are compounded by licensed US pharmacies and shipped free within 48 hours if approved. Unlimited messaging with your care team, provider-managed dose adjustments and quarterly labs are included at no extra cost. Your monthly price does not change as your dose is titrated.
Compare all four GLP-1 options side by side, or start your treatment.
What is MDWatch?
MDWatch is a telehealth service built specifically for seniors, and the design choices show it. Care is led by a named clinical team with published biographies rather than an anonymous provider network. There is a phone number on every screen. The programme includes monthly video visits, a cellular-connected scale that transmits readings without needing a phone or wifi setup, daily monitoring of your health data, and health and nutrition coaching.
It also runs adjacent services that matter for this age group: diabetes management, online doctor visits and continuous glucose monitoring including Dexcom G7 and FreeStyle Libre.
Its compounded pricing is genuinely competitive: $90 per 4-week supply for semaglutide and $140 for tirzepatide, with no membership fee and the same price at every dose. That last commitment matches ours.
It is worth noting how carefully MDWatch labels its own results imagery. Its before and after material carries the disclosure that results have not been independently verified and will vary from person to person. That is more forthcoming than a lot of this category manages.
Pricing: watch the four-week cycle
The headline numbers look almost identical, but the billing units differ, and that changes the annual figure.
TelosRX prices by calendar month, with the visit, medication, shipping, labs and support included:
- Semaglutide, injectable: as low as $99/month
- Microdosed tirzepatide: as low as $116/month
- Oral, needle-free tirzepatide: as low as $129/month
- Standard injectable tirzepatide: as low as $139/month
MDWatch prices per 4-week supply: $90 for compounded semaglutide and $140 for compounded tirzepatide.
There are 13 four-week cycles in a year, not 12. Running each service's own published rates across twelve months, compounded semaglutide comes to roughly $1,170 at MDWatch against $1,188 at TelosRX, which is effectively level. Compounded tirzepatide comes to roughly $1,820 at MDWatch against $1,668 at TelosRX, so TelosRX is around $150 lower across a year. The needle-free oral route at $129 a month and the microdosed protocol at $116 a month are lower again, and MDWatch lists neither.
Key takeaway: On compounded cash pricing these two are close, and MDWatch bundles more human support and hardware than we do. The real decision is not price. It is whether you qualify for Medicare coverage, and whether you want scheduled video visits or a service with no appointments at all.
Medications: what each platform offers
Both platforms work with the same drug class. Semaglutide is a GLP-1 receptor agonist. Tirzepatide is a dual GLP-1 and GIP agonist. These ingredients form the basis of FDA-approved brands and are widely studied for weight management. For background, see the NIH NIDDK overview and the FDA announcement on tirzepatide for weight management.
MDWatch offers compounded semaglutide and compounded tirzepatide as injections, plus the Medicare route to FDA-approved products for eligible patients. Its published material does not list an oral or sublingual GLP-1 or a microdosed protocol.
TelosRX offers injectable semaglutide and injectable tirzepatide, plus needle-free oral tirzepatide and a microdosed tirzepatide protocol for people who want to ease in at a lower dose. Compounded medications from either platform are not FDA-approved and have not been evaluated by the FDA for safety, efficacy or quality.
How the process works
TelosRX is a guided, fully asynchronous program. The intake takes about five minutes. A US-licensed provider reviews it without an appointment, typically within hours, and approved medication ships with free 48-hour delivery. If you are not approved, you pay nothing. There is no video call at any point, which some people prefer and others do not.
MDWatch starts with a free 15-minute consult, with no Medicare card needed to begin, followed by monthly video visits as part of the ongoing programme. If you would rather speak to a clinician face to face and have someone check in each month, that structure is a feature rather than friction. If you want medication without appointments, it is the opposite.
Neither platform prescribes automatically. Any medication is subject to medical approval by a licensed provider. Begin your TelosRX intake to see if you qualify.
Safety and medical oversight
Both platforms work with US-licensed clinicians and dispense compounded medication through licensed pharmacies, and both require provider review before any prescription is issued. TelosRX is LegitScript-certified. MDWatch publishes its clinical team by name with individual biographies and states that it is HIPAA-secure and works with board-certified clinicians.
GLP-1 medications are not right for everyone, and age adds considerations. Older adults are more likely to be taking other medications, more likely to have reduced kidney function, and more exposed to the muscle loss that can accompany rapid weight reduction. Providers screen for issues including a personal or family history of medullary thyroid cancer, pancreatitis and pregnancy.
If you are over 65, a service with monthly video visits and daily monitoring is worth weighing seriously against a cheaper asynchronous option. Share your full medical history during intake on either platform, since approval is subject to medical review and is not guaranteed.
Which service is right for you?
Best if you want a five-minute intake with no scheduled visits, a lower annual cost on tirzepatide, and formats MDWatch does not offer: needle-free oral tirzepatide and a microdosed protocol, with quarterly labs included.
Best if you are 65+ and may qualify for its Medicare GLP-1 Bridge programme, or you want monthly video visits, a connected scale, coaching and a named care team. Check your own coverage before assuming eligibility.
MDWatch has built something genuinely thoughtful for an age group most GLP-1 telehealth ignores. If you are on Medicare, look there first. If you are paying cash and want speed, a lower tirzepatide cost and a choice of formats, TelosRX is the closer fit.
Frequently Asked Questions
Does Medicare cover GLP-1 weight loss medication?
Coverage depends on your specific plan, your diagnosis and current Medicare rules, and it is not universal. MDWatch advertises a Medicare GLP-1 Bridge programme offering FDA-approved GLP-1s for as little as a $50 copay for those who qualify, with visits and labs covered. Confirm your own eligibility directly rather than assuming. Compounded medication is generally a cash purchase at any provider, including TelosRX.
Is MDWatch cheaper than TelosRX?
On compounded semaglutide they are effectively level: MDWatch is $90 per 4-week supply and TelosRX is as low as $99 a month, which across a year is about $1,170 against $1,188 because there are 13 four-week cycles in a year. On compounded tirzepatide TelosRX is lower across a year, roughly $1,668 against $1,820. TelosRX also offers oral tirzepatide as low as $129 a month and a microdosed protocol as low as $116 a month.
Should I use MDWatch if I am over 65?
It is worth looking at first. MDWatch is built for seniors, includes monthly video visits, a connected scale and coaching, and may route you to FDA-approved medication through Medicare. FDA-approved products have been evaluated for safety, efficacy and quality in a way compounded medication has not.
Does either service offer a needle-free GLP-1?
TelosRX offers oral, sublingual tirzepatide as low as $129 a month, plus a microdosed tirzepatide protocol as low as $116 a month. MDWatch does not list a needle-free or microdosed option.
Do I have to attend a video appointment?
At MDWatch, yes: it begins with a free 15-minute consult and includes monthly video visits. At TelosRX, no: the intake is asynchronous and reviewed without an appointment, usually within hours.
Who is MDWatch best for?
Seniors on Medicare who may qualify for covered FDA-approved medication, and anyone who wants scheduled clinical contact, remote monitoring hardware and coaching rather than the lowest possible price. If you are paying cash and want speed and format choice, TelosRX is the closer fit.
TelosRX is LegitScript-certified. Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, efficacy or quality. Any prescription is subject to medical approval by a licensed provider, and approval is not guaranteed. Individual results vary. This article is not medical advice and is not affiliated with Medicare. Medicare coverage depends on your plan, diagnosis and current rules, so confirm eligibility directly. MDWatch details, including pricing, programme features and its Medicare GLP-1 Bridge offer, were checked against its public website in August 2026 and may change.
Start your private evaluation at TelosRX.